Although Wegovy is generally well-tolerated, it isnt for everyone, and some people discontinue it due to side effects
Image Credit: Love Employee / Shutterstock In a recent study published in the journal BMJ Medicine , researchers conducted a target trial emulation to assess associations between different scenarios of glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment and the risk of major adverse cardiovascular events (MACE)
doi: 10.3389/fphar.2021.760581 Received 18 August 2021 Accepted 17 September 2021 Published 26 October 2021 Volume 12 - 2021 Edited by Xuefeng Li, Guangzhou Medical University, China Reviewed by Xiangling Meng, Stanford University, United States Yitian Xu, Houston Methodist Research Institute, United States Qiang Qin, University of Texas MD Anderson Cancer Center, United States Dandan Zhu, University of Texas Health Science Center at Houston, United States Updates Copyright 2021 Wang, Wang, Liao, Hu, Chen, Meng, Gao and Li
The following conflict of interests are reported
Mass spectrometry, often combined with enzymatic digestion, is the most common approach
